This report provides comprehensive information on the current therapeutic developmental pipeline of Intec Pharma ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. http://www.researchmoz.us/intec-pharma-ltd-product-pipeline-review-2015-report.html

1. Intec Pharma ltd. - Product Pipeline Review - 2015
Intec Pharma ltd. - Product Pipeline Review - 2015
Summary
Global Markets Directs, Intec Pharma ltd. - Product Pipeline Review - 2015, provides an overview of the Intec Pharma ltd.s pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Intec Pharma ltd.s, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Intec Pharma ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Intec Pharma ltd.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Intec Pharma ltd.s pipeline products
Reasons to buy
- Evaluate Intec Pharma ltd.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Intec Pharma ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Intec Pharma ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Intec Pharma ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intec Pharma ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Intec Pharma ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
intec Pharma Ltd. Snapshot 4
intec Pharma Ltd. Overview 4
key Information 4
key Facts 4
intec Pharma Ltd. - Research And Development Overview 5
key Therapeutic Areas 5
intec Pharma Ltd. - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
pipeline Products - Combination Treatment Modalities 9
intec Pharma Ltd. - Pipeline Products Glance 10
intec Pharma Ltd. - Clinical Stage Pipeline Products 10
Intec Pharma ltd. - Product Pipeline Review - 2015

2. phase Ii Products/combination Treatment Modalities 10
intec Pharma Ltd. - Early Stage Pipeline Products 11
preclinical Products/combination Treatment Modalities 11
intec Pharma Ltd. - Drug Profiles 12
(carbidopa + Levodopa) 12
product Description 12
mechanism Of Action 12
r&d Progress 12
zaleplon Gr 14
product Description 14
mechanism Of Action 14
r&d Progress 14
drugs For Undisclosed Indication 15
product Description 15
mechanism Of Action 15
r&d Progress 15
intec Pharma Ltd. - Pipeline Analysis 16
intec Pharma Ltd. - Pipeline Products By Target 16
intec Pharma Ltd. - Pipeline Products By Route Of Administration 17
intec Pharma Ltd. - Pipeline Products By Molecule Type 18
intec Pharma Ltd. - Pipeline Products By Mechanism Of Action 19
intec Pharma Ltd. - Recent Pipeline Updates 20
intec Pharma Ltd. - Dormant Projects 21
intec Pharma Ltd. - Locations And Subsidiaries 22
head Office 22
appendix 23
methodology 23
coverage 23
secondary Research 23
primary Research 23
expert Panel Validation 23
contact Us 23
disclaimer 24
list Of Tables
intec Pharma Ltd., Key Information 4
intec Pharma Ltd., Key Facts 4
intec Pharma Ltd. - Pipeline By Indication, 2015 6
intec Pharma Ltd. - Pipeline By Stage Of Development, 2015 7
intec Pharma Ltd. - Monotherapy Products In Pipeline, 2015 8
intec Pharma Ltd. - Combination Treatment Modalities In Pipeline, 2015 9
intec Pharma Ltd. - Phase Ii, 2015 10
intec Pharma Ltd. - Preclinical, 2015 11
intec Pharma Ltd. - Pipeline By Target, 2015 16
intec Pharma Ltd. - Pipeline By Route Of Administration, 2015 17
intec Pharma Ltd. - Pipeline By Molecule Type, 2015 18
intec Pharma Ltd. - Pipeline Products By Mechanism Of Action, 2015 19
intec Pharma Ltd. - Recent Pipeline Updates, 2015 20
intec Pharma Ltd. - Dormant Developmental Projects,2015 21
list Of Figures
intec Pharma Ltd. - Pipeline By Top 10 Indication, 2015 6
intec Pharma Ltd. - Pipeline By Stage Of Development, 2015 7
intec Pharma Ltd. - Monotherapy Products In Pipeline, 2015 8
intec Pharma Ltd. - Pipeline By Top 10 Target, 2015 16
intec Pharma Ltd. - Pipeline Products By Top 10 Mechanism Of Action, 2015 19
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Intec Pharma ltd. - Product Pipeline Review - 2015

3. Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Intec Pharma ltd. - Product Pipeline Review - 2015